HighTower Advisors LLC lessened its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 19.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 300,011 shares of the financial services provider’s stock after selling 74,167 shares during the period. HighTower Advisors LLC owned about 0.08% of CME Group worth $66,251,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the stock. Whipplewood Advisors LLC increased its stake in CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership bought a new stake in CME Group in the fourth quarter valued at approximately $27,000. Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group during the fourth quarter valued at approximately $28,000. Main Street Group LTD purchased a new stake in shares of CME Group during the first quarter valued at approximately $32,000. Finally, Bayban bought a new position in shares of CME Group in the fourth quarter worth approximately $31,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Performance
CME Group stock opened at $281.29 on Tuesday. The stock’s 50 day simple moving average is $260.01 and its two-hundred day simple moving average is $278.05. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $101.15 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 3.32 and a beta of 0.24. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is presently 44.11%.
Analysts Set New Price Targets
Several research analysts recently commented on the stock. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a research note on Thursday, June 18th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Barclays cut their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. UBS Group decreased their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $289.75.
Read Our Latest Analysis on CME Group
Insider Transactions at CME Group
In other news, Director William Shepard acquired 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
